10th International Congress, Psoriasis: from Gene to Clinic

Thursday 5th – Saturday 7th December 2024, London, United Kingdom

We are delighted to announce that registration is now open for the Psoriasis: from Gene to Clinic Congress, and the program is live. The Congress will be held in person from Thursday, December 5th, to Saturday, December 7th, 2024, at the Queen Elizabeth II Centre in London, United Kingdom.

Psoriasis: from Gene to Clinic is the premier global meeting addressing this important long-term skin condition which in 2014 was recognized by the World Health Organization as ‘a serious noncommunicable disease’. Our understanding of the biology of psoriasis has led to a revolution in targeted therapies and patient outcomes. However, many issues remain to be tackled to ensure that care is optimized for all and that we can move from disease treatment to prevention. Such issues include the impact of diversity, lifestyle, and interpersonal variation in disease causes and response to medicines.

Psoriasis: from Gene to Clinic is designed to provide a forum for experts from around the world to present and discuss cutting-edge issues relating to the science of psoriasis and its clinical management. Clinicians, scientists, and members of the biotechnology and pharmaceutical industries will benefit significantly from the scientific program featuring invited lectures and free communications submitted by attending individuals which also provides ample timing for scientific exchanges. The gala evening at the iconic Natural History Museum will allow for informal exchanges and perhaps help establish new collaborations and ideas.

We look forward to welcoming you to the Congress.